Enteral Formula Tolerance in Pediatric Patients
1 other identifier
interventional
22
1 country
1
Brief Summary
The purpose of this prospective study seeks to assess ability to achieve enteral feeding goals with standard polymeric enteral formula in a stable, pediatric tube-fed population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2016
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 18, 2016
CompletedStudy Start
First participant enrolled
May 1, 2016
CompletedFirst Posted
Study publicly available on registry
May 20, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2016
CompletedOctober 21, 2016
March 1, 2016
5 months
March 18, 2016
October 20, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Daily percentage of caloric nutritional goal met
9 days
Secondary Outcomes (7)
Daily percentage of protein goal met
9 days
Daily assessment of gastrointestinal tolerance - stool consistency
9 days
Daily assessment of gastrointestinal tolerance- Stool frequency
9 days
Daily assessment of gastrointestinal tolerance- Vomit
9 days
Daily assessment of gastrointestinal tolerance - Flatulence
9 days
- +2 more secondary outcomes
Study Arms (1)
Enteral formula tube feeding
OTHEREnteral fed children, ages 1-13, with establish enteral feeding access
Interventions
pediatric subjects will be fed a standard pediatric enteral formula tube feeding
Eligibility Criteria
You may qualify if:
- years of age
- Currently tolerating enteral feeding
- Has enteral access
- Requires enteral tube feeding to provide 90% or more of their nutritional needs (without the use of modular(s)) for at least 9 days
- Having obtained his/her and/or his/her legal representative's informed consent
You may not qualify if:
- Condition which contraindicates enteral feeding (i.e. intestinal obstruction)
- Lack of enteral access
- Any condition that would contraindicate use of the study product (i.e. need for severe fluid restriction, cow's milk protein allergy, other)
- Judged to be at risk for poor compliance to the study protocol
- Lack of informed consent
- Currently participating in another conflicting clinical trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's Center for GI and Nutrition
Hollywood, Florida, 33021, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Gerard Minor, MMS, PA-C
Children's Center for GI and Nutrition
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 18, 2016
First Posted
May 20, 2016
Study Start
May 1, 2016
Primary Completion
October 1, 2016
Study Completion
October 1, 2016
Last Updated
October 21, 2016
Record last verified: 2016-03
Data Sharing
- IPD Sharing
- Will not share